Literature DB >> 16819585

Cyclooxygenase-independent effects of aspirin on HT-29 human colon cancer cells, revealed by oligonucleotide microarrays.

Hongying Yin1, Hao Xu, Yongchao Zhao, Weiping Yang, Jing Cheng, Yuxiang Zhou.   

Abstract

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) inhibit proliferation of human colon cancer cells in vitro. Transmission electron microscope detected morphological features of apoptosis in the aspirin-treated (5 mM, 72 h) HT-29 cells in which cyclooxygenoase-2 is catalytically inactive. We investigated aspirin-induced genome-wide expression changes in HT-29 cells and further studied the time- and concentration-dependent expression changes in 374 apoptosis-related genes, which is the first to show stimulation of genome-wide expression of HT-29 cells by aspirin. The most marked effects of aspirin are on ribosome assembly and rRNA metabolism, which could explain why the quasi-apoptotic morphological changes are not accompanied by a classical DNA ladder. These findings demonstrate that aspirin induces apoptosis in HT-29 cells, bolstering the hypothesis that apoptosis may be a mechanism by which NSAIDs inhibit colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819585     DOI: 10.1007/s10529-006-9084-9

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  11 in total

1.  Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.

Authors:  Timothy J Zumwalt; Dominik Wodarz; Natalia L Komarova; Shusuke Toden; Jacob Turner; Jacob Cardenas; John Burn; Andrew T Chan; C Richard Boland; Ajay Goel
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-02

2.  Additive inhibition of colorectal cancer cell lines by aspirin and bortezomib.

Authors:  Ioannis A Voutsadakis; Anna Patrikidou; Konstantinos Tsapakidis; Aristea Karagiannaki; Eleana Hatzidaki; Nikolaos E Stathakis; Christos N Papandreou
Journal:  Int J Colorectal Dis       Date:  2010-04-16       Impact factor: 2.571

3.  Suppression of aspirin-mediated eosinophil activation by prostaglandin E2: Relevance to aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  Kavita Pal; Madison Ramsden; Yun M Shim; Larry Borish; Spencer C Payne; John W Steinke
Journal:  Ann Allergy Asthma Immunol       Date:  2019-09-09       Impact factor: 6.347

4.  SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells.

Authors:  Xin Zhou; Shu-Yan Huang; Jing-Xin Feng; Yan-Yan Gao; Li Zhao; Jun Lu; Bai-Qu Huang; Yu Zhang
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

5.  Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

Authors:  Maria V Grau; Robert S Sandler; Gail McKeown-Eyssen; Robert S Bresalier; Robert W Haile; Elizabeth L Barry; Dennis J Ahnen; Jiang Gui; Robert W Summers; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

6.  NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells.

Authors:  Molykutty John-Aryankalayil; Sanjeewani T Palayoor; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

7.  Simultaneous profiling of 194 distinct receptor transcripts in human cells.

Authors:  Byong H Kang; Karin J Jensen; Jaime A Hatch; Kevin A Janes
Journal:  Sci Signal       Date:  2013-08-06       Impact factor: 8.192

8.  Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.

Authors:  Farhat V N Din; Asta Valanciute; Vanessa P Houde; Daria Zibrova; Kevin A Green; Kei Sakamoto; Dario R Alessi; Malcolm G Dunlop
Journal:  Gastroenterology       Date:  2012-03-06       Impact factor: 22.682

9.  A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer.

Authors:  Aayah Nounu; Alexander Greenhough; Kate J Heesom; Rebecca C Richmond; Jie Zheng; Stephanie J Weinstein; Demetrius Albanes; John A Baron; John L Hopper; Jane C Figueiredo; Polly A Newcomb; Noralane M Lindor; Graham Casey; Elizabeth A Platz; Loïc Le Marchand; Cornelia M Ulrich; Christopher I Li; Fränzel J B van Duijnhoven; Andrea Gsur; Peter T Campbell; Víctor Moreno; Pavel Vodicka; Ludmila Vodickova; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Lori C Sakoda; Martha L Slattery; Robert E Schoen; Marc J Gunter; Sergi Castellví-Bel; Hyeong Rok Kim; Sun-Seog Kweon; Andrew T Chan; Li Li; Wei Zheng; D Timothy Bishop; Daniel D Buchanan; Graham G Giles; Stephen B Gruber; Gad Rennert; Zsofia K Stadler; Tabitha A Harrison; Yi Lin; Temitope O Keku; Michael O Woods; Clemens Schafmayer; Bethany Van Guelpen; Steven Gallinger; Heather Hampel; Sonja I Berndt; Paul D P Pharoah; Annika Lindblom; Alicja Wolk; Anna H Wu; Emily White; Ulrike Peters; David A Drew; Dominique Scherer; Justo Lorenzo Bermejo; Ann C Williams; Caroline L Relton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-14       Impact factor: 4.090

10.  Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial.

Authors:  Sushma S Thomas; Karen W Makar; Lin Li; Yingye Zheng; Peiying Yang; Lisa Levy; Rebecca Yvonne Rudolph; Paul D Lampe; Min Yan; Sanford D Markowitz; Jeannette Bigler; Johanna W Lampe; John D Potter
Journal:  BMC Med Genet       Date:  2015-03-24       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.